Summary
This 8-K filing by Gilead Sciences, Inc. (GILD) primarily reports on corporate governance matters and the outcomes of its 2018 Annual Meeting of Stockholders held on May 9, 2018. Key events include the appointment of Harish Manwani as an independent director to the Board and Compensation Committee, and Kelly A. Kramer as Chair of the Audit Committee. The filing also details the voting results from the Annual Meeting, where stockholders re-elected all nine director nominees, ratified the appointment of Ernst & Young LLP as the independent auditor, and approved, on an advisory basis, the compensation of named executive officers. Notably, two stockholder proposals were voted upon: one requesting an independent Chairman of the Board, which did not pass, and another requesting the Board take steps to permit stockholder action by written consent, which was approved. Investors should note these governance-related updates, especially the director appointments and the outcome of the stockholder proposals which signal areas of focus for shareholder engagement.
Key Highlights
- 1Harish Manwani appointed as an independent director to the Board and Compensation Committee.
- 2Kelly A. Kramer appointed as Chair of the Audit Committee.
- 3All nine director nominees were re-elected by stockholders.
- 4Ernst & Young LLP ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2018.
- 5Stockholders approved, on an advisory basis, the compensation of named executive officers.
- 6Stockholder proposal requesting an independent Chairman of the Board was not approved.
- 7Stockholder proposal for action by written consent was approved by stockholders.